Carlo Giorda

5.7k total citations
117 papers, 3.1k citations indexed

About

Carlo Giorda is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Carlo Giorda has authored 117 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Cardiology and Cardiovascular Medicine and 23 papers in Surgery. Recurrent topics in Carlo Giorda's work include Diabetes Treatment and Management (48 papers), Diabetes Management and Research (33 papers) and Metabolism, Diabetes, and Cancer (18 papers). Carlo Giorda is often cited by papers focused on Diabetes Treatment and Management (48 papers), Diabetes Management and Research (33 papers) and Metabolism, Diabetes, and Cancer (18 papers). Carlo Giorda collaborates with scholars based in Italy, Spain and United States. Carlo Giorda's co-authors include Giuseppina Russo, Salvatore De Cosmo, Antonio Nicolucci, Elisa Nada, Francesca Viazzi, Roberto Pontremoli, Pietro Guida, Antonio Ceriello, Domenico Cucinotta and Roberto Gnavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carlo Giorda

114 papers receiving 3.0k citations

Peers

Carlo Giorda
William G. Herrington United Kingdom
Gunnar V.H. Jensen Denmark
Rudy Bilous United Kingdom
Markku Saraheimo Finland
Josep Franch‐Nadal Spain
Roberto Miccoli Italy
Jan Cederholm Sweden
Pernille Vedel Denmark
José Luis Górriz Spain
C A Cull United Kingdom
William G. Herrington United Kingdom
Carlo Giorda
Citations per year, relative to Carlo Giorda Carlo Giorda (= 1×) peers William G. Herrington

Countries citing papers authored by Carlo Giorda

Since Specialization
Citations

This map shows the geographic impact of Carlo Giorda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Giorda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Giorda more than expected).

Fields of papers citing papers by Carlo Giorda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Giorda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Giorda. The network helps show where Carlo Giorda may publish in the future.

Co-authorship network of co-authors of Carlo Giorda

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Giorda. A scholar is included among the top collaborators of Carlo Giorda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Giorda. Carlo Giorda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masi, Davide, Fabio Baccetti, Besmir Nreu, et al.. (2024). Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control. SHILAP Revista de lepidopterología. 6(1). 420–434. 1 indexed citations
2.
Musacchio, Nicoletta, Davide Masi, Fabio Baccetti, et al.. (2024). A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy. International Journal of Medical Informatics. 190. 105550–105550. 1 indexed citations
3.
Gesuita, Rosaria, Ivana Rabbone, Luisa De Sanctis, et al.. (2023). Trends and cyclic variation in the incidence of childhood type 1 diabetes in two Italian regions over 33 years and during the COVID ‐19 pandemic. Diabetes Obesity and Metabolism. 25(6). 1698–1703. 6 indexed citations
4.
Ceriello, Antonio, Giuseppe Lucisano, Francesco Prattichizzo, et al.. (2023). The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes. The Lancet Regional Health - Europe. 31. 100666–100666. 21 indexed citations
5.
Musacchio, Nicoletta, et al.. (2023). Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes. Journal of Diabetes. 15(3). 224–236. 15 indexed citations
6.
Giorda, Carlo. (2020). Linee guida europee su diabete, pre-diabete e malattie cardiovascolari: cosa c’è di nuovo? Il punto di vista del diabetologo. Giornale italiano di cardiologia. 21(4). 252–255. 1 indexed citations
7.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2019). Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes. Acta Diabetologica. 57(4). 401–408. 8 indexed citations
8.
Viazzi, Francesca, Giuseppina Russo, Antonio Ceriello, et al.. (2018). Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals. Journal of Nephrology. 32(4). 517–525. 30 indexed citations
9.
Gentile, Sandro, Felice Strollo, Francesca Viazzi, et al.. (2018). Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions. Journal of Diabetes Research. 2018. 1–10. 18 indexed citations
10.
Piscitelli, Pamela, Francesca Viazzi, Paola Fioretto, et al.. (2017). Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Scientific Reports. 7(1). 3313–3313. 36 indexed citations
11.
Corona, Giovanni, et al.. (2016). Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors. PLoS ONE. 11(10). e0157915–e0157915. 27 indexed citations
12.
13.
14.
Rossi, Maria Chiara, Riccardo Candido, Antonio Ceriello, et al.. (2014). Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative. Acta Diabetologica. 52(3). 557–571. 39 indexed citations
15.
Giorda, Carlo, Roberta Picariello, Elisa Nada, et al.. (2014). Comparison of direct costs of type 2 diabetes care: Different care models with different outcomes. Nutrition Metabolism and Cardiovascular Diseases. 24(7). 717–724. 11 indexed citations
16.
Cioffi, Giovanni, Pompilio Faggiano, Donata Lucci, et al.. (2013). Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study. Diabetes Research and Clinical Practice. 101(2). 236–242. 10 indexed citations
17.
18.
Giorda, Carlo, et al.. (2010). The IMPROVE study--a multinational, multicentre, observational study in type 2 diabetes: results from the Italian cohort.. PubMed. 81(2). 115–24. 4 indexed citations
19.
Russo, Giuseppina, A. Di Benedetto, Domenico Magazzù, et al.. (2009). Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. Acta Diabetologica. 48(2). 95–101. 24 indexed citations
20.
Giorda, Carlo, et al.. (2003). Secondary prevention of coronary artery disease in high-risk diabetic patients. Nutrition Metabolism and Cardiovascular Diseases. 13(4). 238–243. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William G. Herrington Breakdown of academic impact, for papers by Gunnar V.H. Jensen Breakdown of academic impact, for papers by Rudy Bilous Breakdown of academic impact, for papers by Markku Saraheimo Breakdown of academic impact, for papers by Josep Franch‐Nadal Breakdown of academic impact, for papers by Roberto Miccoli Breakdown of academic impact, for papers by Jan Cederholm Breakdown of academic impact, for papers by Pernille Vedel Breakdown of academic impact, for papers by José Luis Górriz Breakdown of academic impact, for papers by C A Cull
Rankless by CCL
2026